MAIA Biotechnology, Inc., (NYSE American: MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that an abstract ...

On Thursday, April 10, 2025 at 4:00 pm during Oral Poster Presentation: Research 3 at NKF SCM25, Dr. Wolfgang Winkelmayer will present a poster titled “Vadadustat for Treatment of Anemia in Older vs ...

On February 12, 2025, the United States District Court for the District of Delaware denied defendant Parse Biosciences’s (“Parse”) motions for ...

Immutep (IMMP) announces an upcoming poster presentation for the TACTI-004 Phase III trial. The poster will be presented at the European Lung ...

Delivering remarks on behalf of the UN Resident Coordinator in Ghana, H.E. Charles Paul Iheanacho Abani, Ms Jennifer ...

Nagpur: Mandar Mule, a research student from Nagpur University's pharmacy department, won the Best Poster Presentation Award ...

The findings of this model support KIO-104 as a promising therapeutic candidate for both the prevention and treatment of PVR.